PIMG
TEVA icon

Patriot Investment Management Group’s Teva Pharmaceuticals TEVA Stock Holding History

Patriot Investment Management Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,027
Closed -$62K – 592
2020
Q2 		$62K Buy
+5,027
New +$56.9K 0.01% 306

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Patriot Investment Management Group's TEVA Position: Q3 2020 in Review

Patriot Investment Management Group sold out of Teva Pharmaceuticals (TEVA) in Q3 2020, closing a stake of 5,027 shares — an estimated $62K sold.

Patriot Investment Management Group first reported a position in TEVA in Q2 2020 and held it in 1 quarter. The position peaked at $62K in Q2 2020. 444 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

  • Patriot Investment Management Group reported no remaining Teva Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Patriot Investment Management Group sold 5,027 Teva Pharmaceuticals shares in Q3 2020, an estimated $62K.
  • Patriot Investment Management Group first reported a position in Teva Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Patriot Investment Management Group's Teva Pharmaceuticals position peaked at $62K in Q2 2020.
  • 444 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2020.

Based on Patriot Investment Management Group's 13F filing for Q3 2020, filed 23 Oct 2020.